【结 构 式】 |
【分子编号】45007 【品名】4-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]pyridine 【CA登记号】 |
【 分 子 式 】C14H9FN2O 【 分 子 量 】240.2367432 【元素组成】C 70% H 3.78% F 7.91% N 11.66% O 6.66% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(III)1-(4-Fluorophenyl)-2-(4-pyridyl)ethanone (I) was brominated in HOAc to yield bromoketone (II). Reaction of (II) with ammonium oxalate in formamide at 200 C produced a 1:1 mixture of imidazole (III) and oxazole (IV). After isolation of the desired oxazole (IV), its lithiation with n-butyllithium followed by addition to N-methyl-4-piperidinone (V) furnished the corresponding carbinol .
【1】 Zimmerlin, A.G.; Di Padova, F.E.; Revesz, L.; Manning, U.; Gram, H.; Hiestand, P.; Buhl, T.; Feifel, R.; SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 MAP kinase inhibitors. Bioorg Med Chem Lett 2000, 10, 11, 1261. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 45005 | 1-(4-fluorophenyl)-2-(4-pyridinyl)-1-ethanone | C13H10FNO | 详情 | 详情 | |
(II) | 45006 | 2-bromo-1-(4-fluorophenyl)-2-(4-pyridinyl)-1-ethanone | 4736-60-1 | C13H9BrFNO | 详情 | 详情 |
(III) | 45007 | 4-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]pyridine | C14H9FN2O | 详情 | 详情 | |
(IV) | 33798 | 4-[4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine | C14H10FN3 | 详情 | 详情 | |
(V) | 10919 | 1-Methyl-4-piperidone; 1-Methyltetrahydro-4(1H)-pyridinone; N-Methyl-4-piperidone;1-methylpiperidin-4-one | 1445-73-4 | C6H11NO | 详情 | 详情 |
Extended Information